Cargando…

Boosting Natural Killer Cell-Mediated Targeting of Sarcoma Through DNAM-1 and NKG2D

Sarcomas are malignancies of mesenchymal origin that occur in bone and soft tissues. Many are chemo- and radiotherapy resistant, thus conventional treatments fail to increase overall survival. Natural Killer (NK) cells exert anti-tumor activity upon detection of a complex array of tumor ligands, but...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sayitoglu, Ece Canan, Georgoudaki, Anna-Maria, Chrobok, Michael, Ozkazanc, Didem, Josey, Benjamin J., Arif, Muhammad, Kusser, Kim, Hartman, Michelle, Chinn, Tamara M., Potens, Renee, Pamukcu, Cevriye, Krueger, Robin, Zhang, Cheng, Mardinoglu, Adil, Alici, Evren, Temple, Harry Thomas, Sutlu, Tolga, Duru, Adil Doganay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7001093/ https://www.ncbi.nlm.nih.gov/pubmed/32082316 http://dx.doi.org/10.3389/fimmu.2020.00040

Ejemplares similares

Correction: Characterization of zika virus infection of human fetal cardiac mesenchymal stromal cells
por: Rossi, Fiorella, et al.
Publicado: (2021)

Characterization of zika virus infection of human fetal cardiac mesenchymal stromal cells
por: Rossi, Fiorella, et al.
Publicado: (2020)

Functional Assessment for Clinical Use of Serum-Free Adapted NK-92 Cells
por: Chrobok, Michael, et al.
Publicado: (2019)

Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma
por: Duru, Adil Doganay, et al.
Publicado: (2015)

Natural killer cells in clinical development as non-engineered, engineered, and combination therapies
por: Lamers-Kok, Nina, et al.
Publicado: (2022)

Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity
por: Dahlberg, Carin I. M., et al.
Publicado: (2015)

Myeloid maturation potentiates STAT3-mediated atypical IFN-γ signaling and upregulation of PD-1 ligands in AML and MDS
por: Yoyen-Ermis, Digdem, et al.
Publicado: (2019)

Altered expression of ligands for the NKG2D and DNAM-1 activating receptors during HIV-1 infection
por: Vassena, Lia, et al.
Publicado: (2013)

Chemotherapy-elicited upregulation of NKG2D and DNAM-1 ligands as a therapeutic target in multiple myeloma
por: Soriani, Alessandra, et al.
Publicado: (2013)

NKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple Myeloma
por: Fionda, Cinzia, et al.
Publicado: (2015)

The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells
por: Cerboni, Cristina, et al.
Publicado: (2014)

Crystal structures of H-2D(b) in complex with the LCMV-derived peptides GP92 and GP392 explain pleiotropic effects of glycosylation on antigen presentation and immunogenicity
por: Hafstrand, Ida, et al.
Publicado: (2017)

NKG2D and DNAM-1 activating receptors and their ligands in NK-T cell interactions: role in the NK cell-mediated negative regulation of T cell responses
por: Zingoni, Alessandra, et al.
Publicado: (2013)

Boosting Natural Killer Cell Therapies in Glioblastoma Multiforme Using Supramolecular Cationic Inhibitors of Heat Shock Protein 90
por: Saha, Tanmoy, et al.
Publicado: (2021)

Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
por: Han, Bin, et al.
Publicado: (2018)

Low-dose bortezomib increases the expression of NKG2D and DNAM-1 ligands and enhances induced NK and γδ T cell-mediated lysis in multiple myeloma
por: Niu, Chao, et al.
Publicado: (2016)

Renal cell carcinoma escapes NK cell‐mediated immune surveillance through the downregulation of DNAM‐1
por: Tong, Le, et al.
Publicado: (2023)

The Use of Novel Drugs Can Effectively Improve Response, Delay Relapse and Enhance Overall Survival in Multiple Myeloma Patients with Renal Impairment
por: Uttervall, Katarina, et al.
Publicado: (2014)

Role of NKG2D, DNAM-1 and natural cytotoxicity receptors in cytotoxicity toward rhabdomyosarcoma cell lines mediated by resting and IL-15-activated human natural killer cells
por: Boerman, Gerharda H., et al.
Publicado: (2015)

The BET-bromodomain inhibitor JQ1 renders neuroblastoma cells more resistant to NK cell-mediated recognition and killing by downregulating ligands for NKG2D and DNAM-1 receptors
por: Veneziani, Irene, et al.
Publicado: (2019)

Next generation plasma proteome profiling of COVID-19 patients with mild to moderate symptoms
por: Zhong, Wen, et al.
Publicado: (2021)

Genomic Analysis of Abnormal DNAM Methylation in Parathyroid Tumors
por: Li, Qing, et al.
Publicado: (2022)

Editorial: The Impact of Systems Medicine on Human Health and Disease
por: Mardinoglu, Adil, et al.
Publicado: (2016)

Accelerated tumor growth in mice deficient in DNAM-1 receptor
por: Iguchi-Manaka, Akiko, et al.
Publicado: (2008)

The Role of T Cell Costimulation via DNAM-1 in Kidney Transplantation
por: Kraus, Anna K., et al.
Publicado: (2016)

Preliminary evidence of the association between DNAm and orbital volumetry in GO
por: Hu, Ya-Fen, et al.
Publicado: (2020)

A DNAmCULTURE Epigenetic Fingerprint Recapitulates Physiological Aging
por: Minteer, Christopher, et al.
Publicado: (2021)

Further Introduction of DNA Methylation (DNAm) Arrays in Regular Diagnostics
por: Mannens, M. M. A. M., et al.
Publicado: (2022)

Modelling the Effect of SPION Size in a Stent Assisted Magnetic Drug Targeting System with Interparticle Interactions
por: Mardinoglu, Adil, et al.
Publicado: (2015)

DNAM-1 and PVR Regulate Monocyte Migration through Endothelial Junctions
por: Reymond, Nicolas, et al.
Publicado: (2004)

DNAmFitAge: biological age indicator incorporating physical fitness
por: McGreevy, Kristen M., et al.
Publicado: (2023)

TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer
por: Karahan, Zeynep Sena, et al.
Publicado: (2023)

Personalized Cardiovascular Disease Prediction and Treatment—A Review of Existing Strategies and Novel Systems Medicine Tools
por: Björnson, Elias, et al.
Publicado: (2016)

Cancer Metabolism: A Modeling Perspective
por: Ghaffari, Pouyan, et al.
Publicado: (2015)

Predicting growth of the healthy infant using a genome scale metabolic model
por: Nilsson, Avlant, et al.
Publicado: (2017)

DNAM-1: would the real natural killer cell please stand up!
por: Huntington, Nicholas D., et al.
Publicado: (2015)

DNAM-1 controls NK cell activation via an ITT-like motif
por: Zhang, Zhanguang, et al.
Publicado: (2015)

Defective DNAM-1 Dependent Cytotoxicity in Hepatocellular Carcinoma-Infiltrating NK Cells
por: Mantovani, Stefania, et al.
Publicado: (2022)

The DNAm levels of CREB5 (cg11301281) were associated with clopidogrel resistance
por: Li, Jiyi, et al.
Publicado: (2022)

Early TRAIL-engagement elicits potent multimodal targeting of melanoma by CD34(+) progenitor cell-derived NK cells
por: van Vliet, Amanda A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4s7v67svr7jt3f77n2cn1m6vg2